Latest Videos |view all videos
Mayo Clinic cardiologists, Naser Ammash, M.D. and Christopher McLeod, M.B., Ch.B., Ph.D., discuss how to assess stroke risk in patients with adult congenital heart disease (ACHD).
Mayo Clinic electrophysiologist, Paul Friedman, M.D., reviews when premature ventricular complexes (PVCs) require further evaluation, the type of evaluation required, and when treatment is necessary.
Steve R. Ommen, M.D., director, Hypertrophic Cardiomyopathy Clinic at Mayo Clinic, discusses management of symptoms in patients with hypertrophic cardiomyopathy, as well as assessment of risk for sudden cardiac death
Steve R. Ommen, M.D., director, Hypertrophic Cardiomyopathy Clinic at Mayo Clinic, reviews risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy.
Steve R. Ommen, M.D., director, Hypertrophic Cardiomyopathy Clinic at Mayo Clinic, reviews management of symptoms in patients with obstructive hypertrophic cardiomyopathy.
Joseph A. Dearani, M.D., chair, Cardiovascular Surgery at Mayo Clinic, discusses shared medical decision making for patients considering a heart valve intervention
Mayo Clinic cardiologist and sleep expert, Virend Somers, M.D., Ph.D., discusses sleep apnea and its impact on the cardiovascular system as well as treatment options.
Mayo Clinic hematologist, Angela Dispenzieri, M.D., discusses AL amyloidosis treatment including high-dose chemotherapy with stem cell transplantation.
Mayo Clinic physicians, Robert McBane, M.D., (Cardiology) and Ariela Marshall, M.D., (Hematology), discuss the new FDA drug watch list, specifically the direct-acting oral anticoagulants (DOACs).